AE Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$393K Sell
5,700
-42
-0.7% -$2.9K ﹤0.01% 1012
2025
Q1
$399K Buy
5,742
+989
+21% +$68.7K ﹤0.01% 989
2024
Q4
$409K Sell
4,753
-15,324
-76% -$1.32M ﹤0.01% 969
2024
Q3
$2.39M Buy
20,077
+758
+4% +$90.3K 0.02% 482
2024
Q2
$2.76M Buy
19,319
+11,930
+161% +$1.7M 0.03% 446
2024
Q1
$949K Sell
7,389
-56,418
-88% -$7.24M 0.01% 661
2023
Q4
$6.9M Buy
63,807
+36,919
+137% +$3.99M 0.04% 493
2023
Q3
$2.45M Buy
26,888
+4,736
+21% +$431K 0.01% 778
2023
Q2
$1.79M Buy
22,152
+7,846
+55% +$635K 0.01% 877
2023
Q1
$1.14M Buy
14,306
+1,598
+13% +$127K 0.01% 999
2022
Q4
$860K Buy
12,708
+1,524
+14% +$103K 0.01% 1045
2022
Q3
$557K Sell
11,184
-396
-3% -$19.7K ﹤0.01% 1201
2022
Q2
$645K Buy
11,580
+2,246
+24% +$125K 0.01% 1069
2022
Q1
$518K Buy
9,334
+1,954
+26% +$108K ﹤0.01% 1224
2021
Q4
$413K Buy
7,380
+334
+5% +$18.7K ﹤0.01% 1334
2021
Q3
$338K Sell
7,046
-2,236
-24% -$107K ﹤0.01% 1315
2021
Q2
$389K Buy
+9,282
New +$389K ﹤0.01% 1229
2021
Q1
Sell
-7,708
Closed -$269K 1525
2020
Q4
$269K Sell
7,708
-272
-3% -$9.49K ﹤0.01% 1178
2020
Q3
$277K Buy
7,980
+116
+1% +$4.03K ﹤0.01% 1062
2020
Q2
$257K Sell
7,864
-584
-7% -$19.1K ﹤0.01% 1073
2020
Q1
$254K Sell
8,448
-2,748
-25% -$82.6K 0.01% 927
2019
Q4
$324K Hold
11,196
0.01% 872
2019
Q3
$289K Buy
11,196
+102
+0.9% +$2.63K 0.01% 800
2019
Q2
$283K Buy
+11,094
New +$283K 0.01% 772